Glutathione Redox System in β-Thalassemia/Hb E Patients

by Kalpravidh, Ruchaneekorn W., Tangjaidee, Thongchai, Hatairaktham, Suneerat, Charoensakdi, Ratiya, Panichkul, Narumol, Siritanaratkul, Noppadol, Fucharoen, Suthat
Published 2013

Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable...

by Yanpanitch, Orn-uma, Hatairaktham, Suneerat, Charoensakdi, Ratiya, Panichkul, Narumol, Fucharoen, Suthat, Srichairatanakool, Somdet, Siritanaratkul, Noppadol, Kalpravidh, Ruchaneekorn W.
Published 2015

Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasirox

by Taher, Ali T, Porter, John B, Viprakasit, Vip, Kattamis, Antonis, Chuncharunee, Suporn, Sutcharitchan, Pranee, Siritanaratkul, Noppadol, Origa, Raffaella, Karakas, Zeynep, Habr, Dany, Zhu, Zewen, Cappellini, M Domenica
Published 2014

Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients

by Taher, Ali T, Porter, John B, Viprakasit, Vip, Kattamis, Antonis, Chuncharunee, Suporn, Sutcharitchan, Pranee, Siritanaratkul, Noppadol, Galanello, Renzo, Karakas, Zeynep, Lawniczek, Tomasz, Habr, Dany, Ros, Jacqueline, Zhang, Yiyun, Cappellini, M Domenica
Published 2013

Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study

by Taher, Ali T., Porter, John B., Viprakasit, Vip, Kattamis, Antonis, Chuncharunee, Suporn, Sutcharitchan, Pranee, Siritanaratkul, Noppadol, Galanello, Renzo, Karakas, Zeynep, Lawniczek, Tomasz, Habr, Dany, Ros, Jacqueline, Zhu, Zewen, Cappellini, M. Domenica
Published 2013